CANAL Inhibitor Risk Score for Severe Hemophilia A
Estimates early risk of FVIII inhibitor development at first treatment in previously untreated patients with severe hemophilia A.
INSTRUCTIONS
Because inhibitor development typically occurs early during treatment (on average, before the 15th, and almost always before the 50th infusion with FVIII), prediction of inhibitors is most relevant in the very early phases of the treatment with FVIII.
